17Dec 2023
Sun Pharma Gets CDSCO Panel Nod To Manufacture, And Market Etifoxine
HCL Capsules For Anxiety

Sun Pharma Gets CDSCO Panel Nod To Manufacture, And Market Etifoxine HCL Capsules For Anxiety

Sun Pharmaceuticals has received approval from the Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation (CDSCO) to produce and market Etifoxine HCl Capsule 50 mg for generalized anxiety disorder with somatic symptoms. The expert panel also recommended that the company should conduct a post-marketing surveillance (PMS) study to evaluate the drug dependence of Indian subjects.

  • #psychiatry

Like

Save

Share